1,2,5,8-tetrahydroxy anthraquinone has been researched along with casein kinase ii in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 15 (93.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
| Bain, J; Battistutta, R; Cozza, G; di Maira, G; Elliott, M; Gianoncelli, A; Mazzorana, M; Meggio, F; Moro, S; Pagano, MA; Papinutto, E; Pinna, LA; Ruzzene, M; Sarno, S; Zagotto, G | 1 |
| Götz, C; Meng, R; Montenarh, M | 1 |
| Götz, C; Günther, J; Hessenauer, A; Kartarius, S; Montenarh, M; Schneider, CC | 1 |
| Battistutta, R; Lolli, G; Papinutto, E; Pinna, LA; Ranchio, A | 1 |
| Götz, C; Kostelnik, K; Montenarh, M; Wilhelm, N | 1 |
| Alam, M; Bottrill, AR; Burley, G; Cullis, P; Doerig, C; Graciotti, M; Schmid, R; Solyakov, L; Tobin, AB | 1 |
| Arrigoni, G; Cesaro, L; Cifani, P; Franchin, C; Iori, E; James, P; Millioni, R; Pinna, L; Salvi, M | 1 |
| Arrigoni, G; Franchin, C; Pinna, LA; Salvi, M | 1 |
| Gorjup, E; Götz, C; Kartarius, S; Montenarh, M; Schwind, L; Wilhelm, N | 1 |
| Cozza, G; Pinna, LA; Sarno, S; Venerando, A | 1 |
| Bailey, TD; Bobek, G; Buskila, Y; Johnson, AJ; Kersaitis, C; Kueh, S; Wu, MJ; Zaman, MS | 1 |
| Dong, XR; Li, K; Li, QW; Li, ZY; Liu, L; Ma, H; Meng, R; Wu, G; Zhang, S; Zhou, FZ; Zhou, Y | 1 |
| Götz, C; Grässer, F; Kostelnik, KB; Menegatti, J; Montenarh, M; Nalbach, L; Schwind, L; Zimmer, AD | 1 |
| Hong, J; Jie, X; Li, K; Li, Q; Li, Z; Meng, R; Wu, B; Wu, G; Zhang, S; Zhou, X; Zong, Y | 1 |
| Li, K; Li, Q; Li, Z; Liu, L; Meng, R; Wu, G; Zhang, S; Zhou, F; Zhou, Y | 1 |
1 review(s) available for 1,2,5,8-tetrahydroxy anthraquinone and casein kinase ii
| Article | Year |
|---|---|
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
15 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and casein kinase ii
| Article | Year |
|---|---|
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Topics: Animals; Anthraquinones; Apoptosis; Binding Sites; Casein Kinase II; Cell Line; Crystallography, X-Ray; Humans; Jurkat Cells; Kinetics; Molecular Conformation; Protein Kinase Inhibitors; Rats | 2009 |
The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islets.
Topics: Animals; Anthraquinones; Casein Kinase II; Cell Line; Insulin; Insulin Secretion; Islets of Langerhans; Mice | 2010 |
Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.
Topics: Anthraquinones; Apoptosis; Benzimidazoles; Casein Kinase II; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Down-Regulation; Genes, Dominant; Humans; Male; Mutant Proteins; Prostatic Neoplasms; Protein Kinase Inhibitors; Transfection; Triazoles | 2011 |
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.
Topics: Amino Acid Motifs; Anthraquinones; Apoenzymes; Binding Sites; Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Emodin; Histidine; Humans; Models, Molecular; Plant Proteins; Protein Binding; Protein Kinase Inhibitors; Zea mays | 2012 |
Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Amino Acid Sequence; Animals; Anthraquinones; Benzimidazoles; Casein Kinase II; Cell Differentiation; Gene Expression; Gene Expression Regulation, Enzymologic; Glycerolphosphate Dehydrogenase; Lipid Metabolism; Mice; Peptide Fragments; Phosphorylation; Protein Processing, Post-Translational | 2012 |
Malaria protein kinase CK2 (PfCK2) shows novel mechanisms of regulation.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Anthraquinones; Binding Sites; Casein Kinase II; Computational Biology; Humans; Models, Molecular; Molecular Sequence Data; Phosphorylation; Plasmodium falciparum; Protein Structure, Tertiary; Protozoan Proteins | 2014 |
Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Topics: Anthraquinones; Casein Kinase II; HEK293 Cells; Humans; Phosphoproteins; Protein Kinase Inhibitors; Proteome | 2015 |
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin.
Topics: Anthraquinones; Casein Kinase II; Gene Expression Regulation, Enzymologic; Humans; Phosphopeptides; Protein Kinase Inhibitors; Proteomics | 2015 |
Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
Topics: Active Transport, Cell Nucleus; Adipogenesis; Animals; Anthraquinones; Casein Kinase II; Cell Differentiation; Cell Nucleus; Cell Proliferation; Female; Humans; Male; Mesenchymal Stem Cells; Naphthyridines; Phenazines; PPAR gamma | 2015 |
The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.
Topics: Amino Acid Sequence; Animals; Anthraquinones; Casein Kinase II; Humans; Liver; Molecular Dynamics Simulation; Molecular Sequence Data; Protein Kinase Inhibitors; Rats; Sequence Alignment; Zea mays | 2015 |
Protein kinase CK2 regulates metal toxicity in neuronal cells.
Topics: Animals; Anthraquinones; Calcium; Casein Kinase II; Cell Line, Tumor; Gene Knockdown Techniques; Heavy Metal Poisoning; Inhibitory Concentration 50; Intracellular Space; Ions; Metals; Mice; Microscopy, Confocal; Neurons; Poisoning; Protein Kinase Inhibitors; Reproducibility of Results; RNA, Small Interfering; Saccharomyces cerevisiae; Triazoles; Zinc | 2016 |
[The CK2 inhibitor quninalizarin enhances the anti-proliferative effect of icotinib on EGFR-TKIs-resistant cell lines and its underlying mechanisms].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Anthraquinones; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crown Ethers; Down-Regulation; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Humans; Lung Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction | 2016 |
Quinalizarin inhibits adipogenesis through down-regulation of transcription factors and microRNA modulation.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Anthraquinones; Casein Kinase II; CCAAT-Enhancer-Binding Protein-alpha; Cyclic AMP Response Element-Binding Protein; Dimethyl Sulfoxide; Down-Regulation; Mice; MicroRNAs; PPAR gamma | 2017 |
Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.
Topics: Anthraquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Casein Kinase II; Cytokines; Endothelial Cells; Endothelium, Vascular; Humans; Lung Neoplasms; Naphthyridines; Phenazines; Protein Kinase Inhibitors | 2019 |
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines.
Topics: Adenocarcinoma of Lung; Anthraquinones; Antineoplastic Agents; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Crown Ethers; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2019 |